Meeting
2012 Genitourinary Cancers Symposium
11C-choline PET scanning is more accurate than biopsy in assessment of localized prostate cancer planned for radical prostatectomy.
Authors
Ian D. Davis
Ludwig Institute for Cancer Research, Melbourne, Australia
Ian D. Davis , Sze Ting Lee , Lekshmy Shanker , David Clouston , Damien M Bolton , David Angus , David Webb , Nathan Lawrentschuk , Dixon Teck Sing Woon , Stephen Esler , Daryl Lim Joon , Joe Chang , Richard O'Sullivan , Kunthi Pathmaraj , Henri Tochon-Danguy , Graeme Joseph O'Keefe , Andrew Mark Scott
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 30, 2012 (suppl 5; abstr 182)
DOI
10.1200/jco.2012.30.5_suppl.182
Abstract #
182
Poster Bd #
B2
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Detection and delineation of intraprostatic lesions (IPLs) using multiparametric magnetic resonance imaging (mpMRI) and prostate specific membrane antigen positron emission tomography (PSMA PET) for patients with prostate cancer: A systematic review and meta-analysis.
First Author: Aneesh Dhar
Poster
2024 ASCO Genitourinary Cancers Symposium
Daro-PET: A phase 2 trial of darolutamide as a prostate-specific membrane antigen (PSMA) expression enhancer in patients with localized prostate cancer.
First Author: Jose Mauricio Mota
Poster
2023 ASCO Genitourinary Cancers Symposium
Is transrectal ultrasound or magnetic resonance imaging better at estimating prostatic volume for patients with prostate cancer?
First Author: Maxwell Sandberg
Poster
2021 ASCO Annual Meeting
Associations between patient knowledge of others' experiences and treatment choice in men with localized prostate cancer.
First Author: Aaron J. Katz